The Role of Flavonoids as Potential Plant Fungicides in Preventing Human Carcinogenesis: A Short Communication
DOI:
https://doi.org/10.47352/bioactivities.2963-654X.187Keywords:
Plant fungal pathogens, mycotoxins, fungicides, plant-based diet, fruits and vegetables, carcinogenesis, chemopreventionAbstract
In the context of the steadily increasing prevalence of malignant disorders all over the world, identification of any novel possibilities for suppressing carcinogenesis is crucial leading to saving human lives. One of the important sources of exposure to potential carcinogens is food products which can be contaminated with different types of mycotoxins. These structurally diverse chemicals are produced by certain fungi, whereas many of them may be associated with the development of malignant neoplasms in distinct organ systems. In this perspective article, the ability of specific plant secondary metabolites from the class of flavonoids to suppress the release of carcinogenic mycotoxins from certain fungi, mostly the members of Aspergillus and Penicillium genera, is highlighted. This finding might support the development of novel flavonoid-based plant fungicides in the future, to lower the contamination of food products with mycotoxins and thereby also reduce the cancer prevalence in humans. In addition, the application of flavonoids as natural products instead of synthetic chemicals in plant cultivation is probably also more acceptable for final consumers, representing an actual step toward a greener future.
References
[1] A. S. Choudhari, P. C. Mandave, M. Deshpande, P. Ranjekar, and O. Prakash. (2020). "Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice". Frontiers in Pharmacology. 10 : 1614. 10.3389/fphar.2019.01614.
DOI: https://doi.org/10.3389/fphar.2019.01614[2] A. U. Khan, M. S. A. Talucder, M. Das, S. Noreen, and Y. S. Pane. (2021). "Prospect of The Black Pepper (Piper nigrum L.) as Natural Product Used to an Herbal Medicine". Open Access Macedonian Journal of Medical Sciences. 9 (F): 563-573. 10.3889/oamjms.2021.7113.
DOI: https://doi.org/10.3889/oamjms.2021.7113[3] A. M. L. Seca and D. Pinto. (2018). "Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application". International Journal of Molecular Sciences. 19 (1) : 263. 10.3390/ijms19010263.
DOI: https://doi.org/10.3390/ijms19010263[4] R. Kotecha, A. Takami, and J. L. Espinoza. (2016). "Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence". Oncotarget. 7 (32): 52517-52529. 10.18632/oncotarget.9593.
DOI: https://doi.org/10.18632/oncotarget.9593[5] W. Zheng and S. A. Lee. (2009). "Well-done meat intake, heterocyclic amine exposure, and cancer risk". Nutrition and Cancer. 61 (4): 437-446. 10.1080/01635580802710741.
DOI: https://doi.org/10.1080/01635580802710741[6] K. De Ruyck, M. De Boevre, I. Huybrechts, and S. De Saeger. (2015). "Dietary mycotoxins, co-exposure, and carcinogenesis in humans: Short review". Reviews in Mutation Research. 766 : 32-41. 10.1016/j.mrrev.2015.07.003.
DOI: https://doi.org/10.1016/j.mrrev.2015.07.003[7] T. Ekwomadu, M. Mwanza, and A. Musekiwa. (2022). "Mycotoxin-Linked Mutations and Cancer Risk: A Global Health Issue". International Journal of Environmental Research and Public Health. 19 (13) : 7754. 10.3390/ijerph19137754.
DOI: https://doi.org/10.3390/ijerph19137754[8] W. Cao, P. Yu, K. Yang, and D. Cao. (2022). "Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development". Toxicology Mechanisms and Methods. 32 (6): 395-419. 10.1080/15376516.2021.2021339.
DOI: https://doi.org/10.1080/15376516.2021.2021339[9] Y. Liu, C. C. Chang, G. M. Marsh, and F. Wu. (2012). "Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis". European Journal of Cancer. 48 (14): 2125-2136. 10.1016/j.ejca.2012.02.009.
DOI: https://doi.org/10.1016/j.ejca.2012.02.009[10] M. Aslam, A. E. Beg, M. Blaszkewicz, G. H. Degen, and K. Golka. (2005). "Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan". Mycotoxin Research. 21 (3): 164-167. 10.1007/BF02959255.
DOI: https://doi.org/10.1007/BF02959255[11] H. A. Clark and S. M. Snedeker. (2006). "Ochratoxin a: its cancer risk and potential for exposure". Journal of Toxicology and Environmental Health - Part B: Critical Reviews. 9 (3): 265-296. 10.1080/15287390500195570.
DOI: https://doi.org/10.1080/15287390500195570[12] W. C. Gelderblom, S. Abel, C. M. Smuts, J. Marnewick, W. F. Marasas, E. R. Lemmer, and D. Ramljak. (2001). "Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion". Environmental Health Perspectives. 109 (Suppl 2): 291-300. 10.1289/ehp.01109s2291.
DOI: https://doi.org/10.1289/ehp.01109s2291[13] L. Castano-Duque, M. D. Lebar, C. Carter-Wientjes, D. Ambrogio, and K. Rajasekaran. (2022). "Flavonoids Modulate Aspergillus flavus Proliferation and Aflatoxin Production". Journal of Fungi (Basel). 8 (11) : 1211. 10.3390/jof8111211.
DOI: https://doi.org/10.3390/jof8111211[14] P. S. Pok, V. A. Garcia Londono, S. Vicente, S. M. Romero, A. Pacin, M. Tolaba, S. M. Alzamora, and S. L. Resnik. (2020). "Evaluation of citrus flavonoids against Aspergillus parasiticus in maize: Aflatoxins reduction and ultrastructure alterations". Food Chemistry. 318 : 126414. 10.1016/j.foodchem.2020.126414.
DOI: https://doi.org/10.1016/j.foodchem.2020.126414[15] M. P. Salas, C. M. Reynoso, G. Céliz, M. Daz, and S. L. Resnik. (2012). "Efficacy of flavanones obtained from citrus residues to prevent patulin contamination". Food Research International. 48 (2): 930-934. 10.1016/j.foodres.2012.02.003.
DOI: https://doi.org/10.1016/j.foodres.2012.02.003[16] S. M. Romero, M. R. Alberto, M. C. Manca de Nadra, and G. Vaamonde. (2009). "Inhibition of growth and ochratoxin A biosynthesis in Aspergillus carbonarius by flavonoid and nonflavonoid compounds". Mycotoxin Research. 25 (3): 165-170. 10.1007/s12550-009-0026-y.
DOI: https://doi.org/10.1007/s12550-009-0026-y[17] N. Shen, T. Wang, Q. Gan, S. Liu, L. Wang, and B. Jin. (2022). "Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity". Food Chemistry. 383 : 132531. 10.1016/j.foodchem.2022.132531.
DOI: https://doi.org/10.1016/j.foodchem.2022.132531[18] J. M. Al-Khayri, G. R. Sahana, P. Nagella, B. V. Joseph, F. M. Alessa, and M. Q. Al-Mssallem. (2022). "Flavonoids as Potential Anti-Inflammatory Molecules: A Review". Molecules. 27 (9) : 2901. 10.3390/molecules27092901.
DOI: https://doi.org/10.3390/molecules27092901[19] R. K. Al-Ishaq, M. Abotaleb, P. Kubatka, K. Kajo, and D. Busselberg. (2019). "Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels". Biomolecules. 9 (9) : 430. 10.3390/biom9090430.
DOI: https://doi.org/10.3390/biom9090430[20] A. Crozier, J. Burns, A. A. Aziz, A. J. Stewart, H. S. Rabiasz, G. I. Jenkins, C. A. Edwards, and M. E. Lean. (2000). "Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability". Biological Research. 33 (2): 79-88. 10.4067/s0716-97602000000200007.
DOI: https://doi.org/10.4067/S0716-97602000000200007[21] B. H. Parmenter, K. D. Croft, J. M. Hodgson, F. Dalgaard, C. P. Bondonno, J. R. Lewis, A. Cassidy, A. Scalbert, and N. P. Bondonno. (2020). "An overview and update on the epidemiology of flavonoid intake and cardiovascular disease risk". Food & Function journal. 11 (8): 6777-6806. 10.1039/d0fo01118e.
DOI: https://doi.org/10.1039/D0FO01118E[22] K. Sak. (2017). "Intake of Individual Flavonoids and Risk of Carcinogenesis: Overview of Epidemiological Evidence". Nutrition and Cancer. 69 (8): 1119-1150. 10.1080/01635581.2017.1367934.
DOI: https://doi.org/10.1080/01635581.2017.1367934[23] D. M. Kopustinskiene, V. Jakstas, A. Savickas, and J. Bernatoniene. (2020). "Flavonoids as Anticancer Agents". Nutrients. 12 (2) : 457. 10.3390/nu12020457.
DOI: https://doi.org/10.3390/nu12020457[24] H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. (2021). "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries". CA: A Cancer Journal for Clinicians. 71 (3): 209-249. 10.3322/caac.21660.
DOI: https://doi.org/10.3322/caac.21660[25] B. K. Dunn, A. Umar, and E. Richmond. (2016). "Introduction: Cancer chemoprevention and its context". Seminars in Oncology. 43 (1): 19-21. 10.1053/j.seminoncol.2015.11.002.
DOI: https://doi.org/10.1053/j.seminoncol.2015.11.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Katrin Sak
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Authors retain copyright and acknowledge that the Bioactivities is the first publisher, licensed under a Creative Commons Attribution 4.0 International License.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work.
